ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

Breast Density Does Not Raise Breast Cancer Death Rates

August 31, 2012

CMS Draft Coverage Decision Nixes Virtual Colonoscopy

February 13, 2009

NIH Considering Longer grant Award Periods; CCIRC’s New Bosses Crack Dow On Conferences

November 10, 1978

Rising Costs at NCI Threaten To Overtake Slim Increases In Budget Appropriations

March 28, 2014

GI Intergroup called a model for proposed scientific steering committees.

June 10, 2005

NCI Develops Plan For Specialized Centers, But Funding $67.5M Program Depends On New $$

July 5, 1991